Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberous Sclerosis | 99 | 2023 | 1029 | 14.030 |
Why?
|
TOR Serine-Threonine Kinases | 42 | 2023 | 2109 | 4.250 |
Why?
|
Spastic Paraplegia, Hereditary | 15 | 2024 | 157 | 3.550 |
Why?
|
Autistic Disorder | 21 | 2023 | 1185 | 3.470 |
Why?
|
Tumor Suppressor Proteins | 33 | 2023 | 2849 | 2.510 |
Why?
|
Neurons | 41 | 2024 | 9338 | 2.400 |
Why?
|
Induced Pluripotent Stem Cells | 11 | 2023 | 1736 | 2.230 |
Why?
|
Adaptor Protein Complex 4 | 9 | 2023 | 38 | 2.220 |
Why?
|
Purkinje Cells | 6 | 2021 | 224 | 1.830 |
Why?
|
Epilepsy | 24 | 2023 | 3310 | 1.780 |
Why?
|
Cilia | 4 | 2021 | 466 | 1.780 |
Why?
|
Survival of Motor Neuron 1 Protein | 6 | 2018 | 64 | 1.690 |
Why?
|
Sturge-Weber Syndrome | 7 | 2021 | 91 | 1.630 |
Why?
|
Seizures | 15 | 2023 | 2859 | 1.500 |
Why?
|
Cerebellum | 8 | 2018 | 1488 | 1.400 |
Why?
|
Brain | 62 | 2023 | 26385 | 1.380 |
Why?
|
GTPase-Activating Proteins | 3 | 2022 | 498 | 1.340 |
Why?
|
Chromosome Disorders | 9 | 2023 | 514 | 1.310 |
Why?
|
Axons | 10 | 2022 | 1684 | 1.200 |
Why?
|
Sirolimus | 11 | 2020 | 1564 | 1.180 |
Why?
|
Rett Syndrome | 4 | 2018 | 165 | 1.150 |
Why?
|
Muscular Atrophy, Spinal | 5 | 2018 | 259 | 1.140 |
Why?
|
Spasms, Infantile | 6 | 2021 | 305 | 1.140 |
Why?
|
ARNTL Transcription Factors | 2 | 2017 | 98 | 1.070 |
Why?
|
Behavior, Animal | 6 | 2020 | 1881 | 1.050 |
Why?
|
Signal Transduction | 30 | 2023 | 23403 | 1.040 |
Why?
|
Hamartoma Syndrome, Multiple | 5 | 2023 | 111 | 1.000 |
Why?
|
Chromosome Deletion | 10 | 2023 | 1401 | 0.980 |
Why?
|
Autophagy | 7 | 2021 | 1300 | 0.950 |
Why?
|
Pentylenetetrazole | 2 | 2021 | 69 | 0.950 |
Why?
|
Convulsants | 2 | 2021 | 70 | 0.940 |
Why?
|
Fragile X Mental Retardation Protein | 2 | 2021 | 117 | 0.900 |
Why?
|
Animals | 95 | 2023 | 168757 | 0.860 |
Why?
|
Disease Models, Animal | 27 | 2023 | 18029 | 0.840 |
Why?
|
rhoA GTP-Binding Protein | 3 | 2021 | 241 | 0.820 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2023 | 255 | 0.780 |
Why?
|
Chromosomes, Human, Pair 16 | 3 | 2021 | 354 | 0.760 |
Why?
|
Developmental Disabilities | 8 | 2021 | 1456 | 0.760 |
Why?
|
Electroencephalography | 23 | 2022 | 6150 | 0.740 |
Why?
|
Vigabatrin | 5 | 2019 | 92 | 0.720 |
Why?
|
PTEN Phosphohydrolase | 11 | 2023 | 1142 | 0.700 |
Why?
|
Child, Preschool | 72 | 2023 | 41006 | 0.690 |
Why?
|
Heat-Shock Response | 1 | 2020 | 165 | 0.690 |
Why?
|
Corpus Callosum | 3 | 2021 | 737 | 0.690 |
Why?
|
Mice | 55 | 2023 | 81183 | 0.670 |
Why?
|
Genetic Predisposition to Disease | 9 | 2022 | 17446 | 0.670 |
Why?
|
Protein Biosynthesis | 5 | 2015 | 2126 | 0.670 |
Why?
|
Receptor, EphA1 | 3 | 2010 | 20 | 0.660 |
Why?
|
Dendritic Spines | 3 | 2015 | 233 | 0.640 |
Why?
|
Social Isolation | 1 | 2021 | 365 | 0.640 |
Why?
|
Nerve Tissue Proteins | 8 | 2023 | 4462 | 0.630 |
Why?
|
Central Nervous System Agents | 1 | 2018 | 72 | 0.620 |
Why?
|
Humans | 209 | 2024 | 744343 | 0.620 |
Why?
|
Aconitate Hydratase | 1 | 2017 | 15 | 0.610 |
Why?
|
Mutation | 28 | 2024 | 29786 | 0.600 |
Why?
|
Connective Tissue Growth Factor | 1 | 2017 | 96 | 0.580 |
Why?
|
Genetic Association Studies | 5 | 2022 | 2703 | 0.580 |
Why?
|
Nerve Net | 5 | 2021 | 2174 | 0.570 |
Why?
|
Synaptic Transmission | 2 | 2021 | 1178 | 0.570 |
Why?
|
Multiprotein Complexes | 10 | 2017 | 1119 | 0.570 |
Why?
|
Myelin Sheath | 2 | 2019 | 652 | 0.570 |
Why?
|
Anticonvulsants | 9 | 2023 | 1916 | 0.560 |
Why?
|
Lysosomal Storage Diseases, Nervous System | 1 | 2015 | 9 | 0.560 |
Why?
|
Fasting | 1 | 2022 | 1593 | 0.550 |
Why?
|
Cells, Cultured | 23 | 2021 | 19229 | 0.550 |
Why?
|
Phenotype | 21 | 2023 | 16365 | 0.540 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2015 | 44 | 0.540 |
Why?
|
Models, Biological | 7 | 2021 | 9583 | 0.540 |
Why?
|
Magnetic Resonance Imaging | 27 | 2022 | 35421 | 0.530 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2014 | 31 | 0.520 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2015 | 56 | 0.520 |
Why?
|
Mice, Knockout | 18 | 2022 | 14557 | 0.520 |
Why?
|
Activating Transcription Factor 3 | 1 | 2015 | 54 | 0.510 |
Why?
|
Ataxia | 1 | 2017 | 304 | 0.510 |
Why?
|
Adolescent Development | 1 | 2018 | 278 | 0.510 |
Why?
|
Growth Cones | 5 | 2010 | 117 | 0.510 |
Why?
|
Cystadenoma | 1 | 2014 | 84 | 0.500 |
Why?
|
Gelsolin | 1 | 2015 | 190 | 0.500 |
Why?
|
Neuroprotective Agents | 3 | 2019 | 941 | 0.500 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 51 | 0.490 |
Why?
|
Social Behavior | 3 | 2018 | 1127 | 0.490 |
Why?
|
Malformations of Cortical Development | 4 | 2022 | 200 | 0.480 |
Why?
|
Motor Neurons | 3 | 2018 | 844 | 0.480 |
Why?
|
Plagiarism | 1 | 2014 | 22 | 0.480 |
Why?
|
Infant | 50 | 2023 | 35136 | 0.480 |
Why?
|
Cerebral Palsy | 4 | 2022 | 459 | 0.480 |
Why?
|
Neural Pathways | 6 | 2019 | 2972 | 0.470 |
Why?
|
Receptors, Eph Family | 4 | 2010 | 44 | 0.470 |
Why?
|
Synapses | 5 | 2018 | 1728 | 0.460 |
Why?
|
Retinitis Pigmentosa | 1 | 2017 | 386 | 0.460 |
Why?
|
Rhabdomyoma | 3 | 2008 | 57 | 0.460 |
Why?
|
Astrocytoma | 3 | 2020 | 790 | 0.460 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 349 | 0.450 |
Why?
|
Child | 61 | 2023 | 77709 | 0.450 |
Why?
|
Behavior | 3 | 2015 | 561 | 0.450 |
Why?
|
MicroRNAs | 5 | 2018 | 3752 | 0.450 |
Why?
|
Child Behavior | 2 | 2018 | 839 | 0.450 |
Why?
|
Angiomatosis | 1 | 2013 | 49 | 0.440 |
Why?
|
Status Epilepticus | 4 | 2011 | 444 | 0.440 |
Why?
|
Circadian Clocks | 1 | 2015 | 171 | 0.440 |
Why?
|
Diffusion Tensor Imaging | 12 | 2020 | 2305 | 0.430 |
Why?
|
Neural Stem Cells | 1 | 2020 | 851 | 0.430 |
Why?
|
Hemangiosarcoma | 1 | 2014 | 239 | 0.420 |
Why?
|
Nerve Fibers, Myelinated | 6 | 2015 | 957 | 0.420 |
Why?
|
Genes, Duplicate | 1 | 2012 | 33 | 0.420 |
Why?
|
Child Development | 3 | 2019 | 2223 | 0.410 |
Why?
|
Male | 102 | 2023 | 350118 | 0.410 |
Why?
|
Pluripotent Stem Cells | 4 | 2023 | 795 | 0.410 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2012 | 658 | 0.400 |
Why?
|
Rats | 21 | 2023 | 24260 | 0.400 |
Why?
|
Child Development Disorders, Pervasive | 6 | 2014 | 615 | 0.400 |
Why?
|
Female | 103 | 2024 | 380194 | 0.390 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2022 | 2915 | 0.390 |
Why?
|
Migraine Disorders | 1 | 2023 | 1620 | 0.390 |
Why?
|
Alleles | 5 | 2021 | 6933 | 0.390 |
Why?
|
Mental Disorders | 6 | 2022 | 6600 | 0.390 |
Why?
|
Protein Kinases | 3 | 2014 | 1640 | 0.380 |
Why?
|
Genetic Counseling | 1 | 2015 | 600 | 0.380 |
Why?
|
Evoked Potentials | 1 | 2017 | 1056 | 0.380 |
Why?
|
Ephrin-A1 | 2 | 2010 | 9 | 0.380 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 3 | 2009 | 437 | 0.370 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 611 | 0.370 |
Why?
|
Adolescent | 47 | 2023 | 85781 | 0.360 |
Why?
|
Central Nervous System Diseases | 1 | 2014 | 518 | 0.360 |
Why?
|
Epilepsies, Partial | 4 | 2021 | 436 | 0.360 |
Why?
|
Heart Neoplasms | 3 | 2008 | 374 | 0.360 |
Why?
|
Adolescent Behavior | 1 | 2018 | 1151 | 0.350 |
Why?
|
Neuronal Plasticity | 2 | 2016 | 1422 | 0.350 |
Why?
|
Genetic Testing | 5 | 2023 | 3444 | 0.340 |
Why?
|
Mice, Inbred CBA | 3 | 2021 | 448 | 0.340 |
Why?
|
Editorial Policies | 1 | 2014 | 451 | 0.330 |
Why?
|
Neurogenesis | 4 | 2020 | 838 | 0.330 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2021 | 140 | 0.330 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2010 | 199 | 0.320 |
Why?
|
Stem Cells | 2 | 2020 | 3567 | 0.320 |
Why?
|
Maze Learning | 3 | 2017 | 478 | 0.320 |
Why?
|
Protein Tyrosine Phosphatases | 3 | 1995 | 473 | 0.320 |
Why?
|
Chromosomes, Human, Pair 22 | 7 | 2023 | 351 | 0.320 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8949 | 0.310 |
Why?
|
Proteins | 8 | 2024 | 6103 | 0.310 |
Why?
|
Cognition Disorders | 4 | 2018 | 4043 | 0.310 |
Why?
|
Spasm | 1 | 2008 | 121 | 0.300 |
Why?
|
Neuropeptides | 2 | 2011 | 942 | 0.300 |
Why?
|
Guanine Nucleotide Exchange Factors | 4 | 2006 | 581 | 0.300 |
Why?
|
Memory | 1 | 2017 | 2174 | 0.300 |
Why?
|
Hippocampus | 6 | 2020 | 3675 | 0.300 |
Why?
|
Anxiety | 4 | 2023 | 4297 | 0.290 |
Why?
|
Heterozygote | 6 | 2021 | 2804 | 0.290 |
Why?
|
Nervous System Diseases | 2 | 2014 | 1622 | 0.280 |
Why?
|
DNA Copy Number Variations | 4 | 2022 | 1941 | 0.280 |
Why?
|
Gene Expression | 6 | 2021 | 7799 | 0.280 |
Why?
|
Protein Transport | 2 | 2024 | 1988 | 0.270 |
Why?
|
Germ-Line Mutation | 4 | 2021 | 1788 | 0.270 |
Why?
|
Immunosuppressive Agents | 3 | 2018 | 4149 | 0.270 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2018 | 2737 | 0.270 |
Why?
|
Central Nervous System | 2 | 2011 | 1357 | 0.270 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2014 | 1861 | 0.270 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2624 | 0.260 |
Why?
|
Fragile X Syndrome | 2 | 2018 | 115 | 0.260 |
Why?
|
Grooming | 2 | 2017 | 37 | 0.260 |
Why?
|
Triiodobenzoic Acids | 1 | 2005 | 124 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2020 | 112 | 0.240 |
Why?
|
Neocortex | 2 | 2020 | 400 | 0.240 |
Why?
|
Checklist | 3 | 2023 | 833 | 0.240 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 21827 | 0.240 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.240 |
Why?
|
Embryo, Mammalian | 8 | 2011 | 1701 | 0.230 |
Why?
|
Anisotropy | 9 | 2019 | 1265 | 0.230 |
Why?
|
Cell Movement | 2 | 2020 | 5217 | 0.230 |
Why?
|
Lysosomes | 3 | 2021 | 893 | 0.230 |
Why?
|
Granulosa Cell Tumor | 1 | 2024 | 71 | 0.230 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 1 | 2023 | 70 | 0.220 |
Why?
|
Endometrial Hyperplasia | 1 | 2024 | 97 | 0.220 |
Why?
|
Genetic Variation | 3 | 2023 | 6544 | 0.210 |
Why?
|
Vocalization, Animal | 2 | 2012 | 87 | 0.210 |
Why?
|
Lissencephaly | 2 | 2020 | 38 | 0.210 |
Why?
|
Encephalitis | 3 | 2011 | 423 | 0.210 |
Why?
|
Neuropsychiatry | 2 | 2019 | 55 | 0.210 |
Why?
|
Models, Genetic | 2 | 2012 | 3494 | 0.210 |
Why?
|
Mice, Transgenic | 10 | 2018 | 9734 | 0.200 |
Why?
|
Cerebral Cortex | 6 | 2019 | 5708 | 0.200 |
Why?
|
Brain Diseases | 3 | 2018 | 1563 | 0.200 |
Why?
|
Action Potentials | 2 | 2019 | 1806 | 0.200 |
Why?
|
Tyrosine | 2 | 2006 | 1461 | 0.200 |
Why?
|
Language Development | 2 | 2019 | 187 | 0.200 |
Why?
|
Rats, Long-Evans | 3 | 2017 | 387 | 0.200 |
Why?
|
Evoked Potentials, Visual | 2 | 2015 | 427 | 0.200 |
Why?
|
RNA, Messenger | 4 | 2014 | 13033 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2020 | 2503 | 0.200 |
Why?
|
Rare Diseases | 3 | 2022 | 553 | 0.200 |
Why?
|
Genotype | 7 | 2021 | 12951 | 0.200 |
Why?
|
Papilloma | 1 | 2022 | 148 | 0.190 |
Why?
|
Endocannabinoids | 1 | 2022 | 116 | 0.190 |
Why?
|
Young Adult | 23 | 2023 | 56430 | 0.190 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 173 | 0.190 |
Why?
|
Up-Regulation | 3 | 2021 | 4217 | 0.190 |
Why?
|
Mice, 129 Strain | 1 | 2021 | 386 | 0.180 |
Why?
|
Longitudinal Studies | 14 | 2021 | 13989 | 0.180 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2938 | 0.180 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2020 | 70 | 0.180 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2015 | 3327 | 0.180 |
Why?
|
Carbamazepine | 2 | 2017 | 229 | 0.180 |
Why?
|
Biomedical Research | 1 | 2016 | 3309 | 0.180 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3079 | 0.180 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5853 | 0.180 |
Why?
|
Seizures, Febrile | 2 | 2011 | 111 | 0.180 |
Why?
|
Organic Chemicals | 1 | 2021 | 211 | 0.180 |
Why?
|
trans-Golgi Network | 1 | 2020 | 33 | 0.180 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2408 | 0.180 |
Why?
|
Carrier Proteins | 4 | 2011 | 5021 | 0.180 |
Why?
|
Reproducibility of Results | 13 | 2023 | 19905 | 0.180 |
Why?
|
Organoids | 2 | 2023 | 701 | 0.180 |
Why?
|
RNA, Small Interfering | 4 | 2015 | 3505 | 0.180 |
Why?
|
Benzoquinones | 1 | 2020 | 201 | 0.180 |
Why?
|
Penetrance | 1 | 2021 | 381 | 0.170 |
Why?
|
Oxidative Stress | 3 | 2010 | 3086 | 0.170 |
Why?
|
Brain Neoplasms | 4 | 2020 | 8863 | 0.170 |
Why?
|
Glycogen Storage Disease Type II | 1 | 1999 | 41 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2022 | 326 | 0.170 |
Why?
|
Software | 1 | 2014 | 4443 | 0.170 |
Why?
|
Gene Expression Regulation | 6 | 2019 | 12072 | 0.170 |
Why?
|
Blotting, Western | 6 | 2015 | 5179 | 0.170 |
Why?
|
Cognition | 5 | 2021 | 6770 | 0.170 |
Why?
|
Reactive Oxygen Species | 3 | 2013 | 2077 | 0.170 |
Why?
|
Excitatory Postsynaptic Potentials | 3 | 2016 | 377 | 0.170 |
Why?
|
Genes, Lethal | 1 | 2019 | 242 | 0.170 |
Why?
|
Kidney Neoplasms | 2 | 2017 | 4262 | 0.170 |
Why?
|
Scalp | 2 | 2019 | 380 | 0.170 |
Why?
|
Hamartoma | 1 | 2021 | 238 | 0.170 |
Why?
|
Computational Biology | 1 | 2011 | 3521 | 0.160 |
Why?
|
Endothelial Cells | 4 | 2022 | 3479 | 0.160 |
Why?
|
Survival of Motor Neuron 2 Protein | 1 | 2018 | 48 | 0.160 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 320 | 0.160 |
Why?
|
Capillaries | 1 | 2021 | 773 | 0.160 |
Why?
|
Pedigree | 5 | 2022 | 4644 | 0.160 |
Why?
|
Phospholipase C beta | 2 | 2021 | 50 | 0.160 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2017 | 23 | 0.160 |
Why?
|
Research Report | 1 | 2021 | 355 | 0.160 |
Why?
|
Cell Differentiation | 6 | 2023 | 11483 | 0.160 |
Why?
|
Gliosis | 3 | 2019 | 245 | 0.160 |
Why?
|
Ribosomes | 1 | 2021 | 500 | 0.160 |
Why?
|
Visual Perception | 2 | 2018 | 1420 | 0.160 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2505 | 0.150 |
Why?
|
Neonatal Screening | 1 | 2022 | 591 | 0.150 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7279 | 0.150 |
Why?
|
Microarray Analysis | 2 | 2022 | 767 | 0.150 |
Why?
|
Thalamus | 2 | 1995 | 1023 | 0.150 |
Why?
|
World Health Organization | 1 | 2023 | 1318 | 0.150 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2023 | 1121 | 0.150 |
Why?
|
Stereotypic Movement Disorder | 1 | 2017 | 29 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 434 | 0.150 |
Why?
|
Microcephaly | 1 | 2021 | 432 | 0.150 |
Why?
|
Models, Neurological | 3 | 2015 | 1774 | 0.150 |
Why?
|
Infant, Newborn | 13 | 2022 | 25625 | 0.150 |
Why?
|
Phosphorylation | 8 | 2015 | 8436 | 0.150 |
Why?
|
Vesicular Transport Proteins | 1 | 2020 | 377 | 0.150 |
Why?
|
Age Factors | 6 | 2021 | 18370 | 0.140 |
Why?
|
Barbiturates | 1 | 2017 | 114 | 0.140 |
Why?
|
Species Specificity | 1 | 2021 | 2478 | 0.140 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6386 | 0.140 |
Why?
|
Mosaicism | 2 | 2019 | 441 | 0.140 |
Why?
|
Receptor, EphA4 | 2 | 2006 | 18 | 0.140 |
Why?
|
Congresses as Topic | 1 | 2021 | 764 | 0.140 |
Why?
|
Databases, Genetic | 1 | 2023 | 1783 | 0.140 |
Why?
|
Cell Line | 8 | 2021 | 15997 | 0.140 |
Why?
|
Segmental Duplications, Genomic | 1 | 2016 | 19 | 0.140 |
Why?
|
Allosteric Regulation | 1 | 2017 | 408 | 0.140 |
Why?
|
Vascular Malformations | 1 | 2022 | 454 | 0.140 |
Why?
|
Ribonuclease III | 1 | 2018 | 275 | 0.140 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 625 | 0.140 |
Why?
|
Amino Acids | 1 | 2022 | 1736 | 0.140 |
Why?
|
Cell Respiration | 1 | 2016 | 201 | 0.140 |
Why?
|
Microscopy, Atomic Force | 1 | 2016 | 250 | 0.130 |
Why?
|
Diencephalon | 1 | 1995 | 56 | 0.130 |
Why?
|
Angiofibroma | 1 | 2016 | 68 | 0.130 |
Why?
|
Apnea | 1 | 2017 | 195 | 0.130 |
Why?
|
Cerebellar Diseases | 1 | 2018 | 226 | 0.130 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2017 | 191 | 0.130 |
Why?
|
GABA Agents | 1 | 2015 | 42 | 0.130 |
Why?
|
Basal Ganglia | 1 | 2018 | 546 | 0.130 |
Why?
|
Coma | 2 | 2017 | 475 | 0.130 |
Why?
|
Brain Waves | 1 | 2020 | 401 | 0.130 |
Why?
|
Albinism | 1 | 2015 | 25 | 0.130 |
Why?
|
Facial Neoplasms | 1 | 2016 | 121 | 0.130 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2013 | 1213 | 0.130 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 297 | 0.130 |
Why?
|
Microscopy | 1 | 2020 | 903 | 0.130 |
Why?
|
Frameshift Mutation | 1 | 2017 | 399 | 0.130 |
Why?
|
Adult | 22 | 2024 | 214055 | 0.130 |
Why?
|
Age of Onset | 3 | 2021 | 3271 | 0.130 |
Why?
|
Huntington Disease | 1 | 2022 | 1124 | 0.130 |
Why?
|
3' Untranslated Regions | 2 | 2014 | 513 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2020 | 687 | 0.130 |
Why?
|
Immunoprecipitation | 1 | 2017 | 905 | 0.120 |
Why?
|
rho GTP-Binding Proteins | 3 | 2005 | 293 | 0.120 |
Why?
|
Animals, Newborn | 6 | 2010 | 2726 | 0.120 |
Why?
|
Receptor, EphA7 | 1 | 2014 | 6 | 0.120 |
Why?
|
Cell Size | 3 | 2012 | 643 | 0.120 |
Why?
|
p120 GTPase Activating Protein | 1 | 2014 | 39 | 0.120 |
Why?
|
Down-Regulation | 2 | 2020 | 3002 | 0.120 |
Why?
|
Presynaptic Terminals | 1 | 2016 | 302 | 0.120 |
Why?
|
Gene Knockdown Techniques | 3 | 2014 | 1655 | 0.120 |
Why?
|
Pattern Recognition, Automated | 2 | 2012 | 1005 | 0.120 |
Why?
|
Injections, Intraperitoneal | 1 | 2014 | 425 | 0.120 |
Why?
|
Endometrial Neoplasms | 1 | 2024 | 1353 | 0.120 |
Why?
|
Receptor, EphB4 | 1 | 2014 | 38 | 0.120 |
Why?
|
Imidazoles | 2 | 2017 | 1206 | 0.120 |
Why?
|
Exodeoxyribonucleases | 1 | 2015 | 180 | 0.120 |
Why?
|
Cytoskeletal Proteins | 1 | 2020 | 1364 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2017 | 2564 | 0.120 |
Why?
|
Neurites | 1 | 2016 | 388 | 0.120 |
Why?
|
Prospective Studies | 15 | 2023 | 53288 | 0.120 |
Why?
|
Association Learning | 1 | 2015 | 224 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4751 | 0.110 |
Why?
|
Aging | 3 | 2020 | 8664 | 0.110 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2015 | 204 | 0.110 |
Why?
|
Atrophy | 2 | 2013 | 1583 | 0.110 |
Why?
|
Electroretinography | 1 | 2015 | 509 | 0.110 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 1 | 2013 | 45 | 0.110 |
Why?
|
Social Environment | 1 | 2018 | 1023 | 0.110 |
Why?
|
Oligodendroglia | 1 | 2017 | 517 | 0.110 |
Why?
|
Riluzole | 1 | 2013 | 55 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 3 | 2018 | 4042 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 5 | 2015 | 8301 | 0.110 |
Why?
|
Peroxisomes | 1 | 2013 | 58 | 0.110 |
Why?
|
Mitochondria | 3 | 2020 | 3520 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 2015 | 433 | 0.110 |
Why?
|
Retina | 2 | 2017 | 2616 | 0.110 |
Why?
|
Hydrocephalus | 1 | 1999 | 748 | 0.110 |
Why?
|
Rotarod Performance Test | 1 | 2012 | 64 | 0.110 |
Why?
|
Introns | 1 | 2015 | 991 | 0.110 |
Why?
|
Hypothalamus | 1 | 2018 | 1063 | 0.110 |
Why?
|
Ubiquitination | 1 | 2017 | 1012 | 0.110 |
Why?
|
Temporal Lobe | 1 | 2020 | 1670 | 0.100 |
Why?
|
Time Factors | 6 | 2020 | 40075 | 0.100 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 25043 | 0.100 |
Why?
|
Cohort Studies | 8 | 2022 | 40561 | 0.100 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1866 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1581 | 0.100 |
Why?
|
Cytosol | 1 | 2015 | 901 | 0.100 |
Why?
|
Retinal Pigment Epithelium | 1 | 2015 | 302 | 0.100 |
Why?
|
Receptors, Muscarinic | 1 | 1992 | 156 | 0.100 |
Why?
|
Hand | 1 | 2017 | 884 | 0.100 |
Why?
|
Receptors, Opioid | 1 | 1992 | 155 | 0.100 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1152 | 0.100 |
Why?
|
Gene Knockout Techniques | 2 | 2012 | 809 | 0.100 |
Why?
|
Stem Cell Factor | 1 | 2012 | 219 | 0.100 |
Why?
|
Animals, Genetically Modified | 2 | 2020 | 1549 | 0.100 |
Why?
|
Contrast Media | 1 | 2005 | 5300 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3920 | 0.100 |
Why?
|
Genes | 1 | 2015 | 1893 | 0.100 |
Why?
|
Sequence Deletion | 1 | 2016 | 1526 | 0.100 |
Why?
|
Cell Shape | 1 | 2012 | 375 | 0.100 |
Why?
|
Clinical Trials as Topic | 3 | 2016 | 7913 | 0.100 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11366 | 0.100 |
Why?
|
Transfection | 3 | 2015 | 5892 | 0.100 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2635 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2015 | 635 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 783 | 0.100 |
Why?
|
N-Methylaspartate | 1 | 2011 | 231 | 0.100 |
Why?
|
Immunity, Active | 1 | 2010 | 60 | 0.100 |
Why?
|
Reflex | 1 | 2012 | 365 | 0.100 |
Why?
|
Neuropsychological Tests | 6 | 2023 | 6993 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 692 | 0.090 |
Why?
|
Amygdala | 1 | 2018 | 1315 | 0.090 |
Why?
|
Goals | 1 | 2016 | 706 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3638 | 0.090 |
Why?
|
Trisomy | 1 | 2012 | 266 | 0.090 |
Why?
|
Apoptosis | 5 | 2012 | 9727 | 0.090 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2012 | 300 | 0.090 |
Why?
|
Prenatal Diagnosis | 2 | 2008 | 1236 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 789 | 0.090 |
Why?
|
Cerebellar Cortex | 1 | 1990 | 107 | 0.090 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 434 | 0.090 |
Why?
|
HEK293 Cells | 3 | 2014 | 4204 | 0.090 |
Why?
|
Genetic Engineering | 1 | 2016 | 951 | 0.090 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2010 | 141 | 0.090 |
Why?
|
Family Health | 1 | 2015 | 1282 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1425 | 0.090 |
Why?
|
Cataract | 1 | 2015 | 834 | 0.090 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1276 | 0.090 |
Why?
|
Transcription Factor CHOP | 1 | 2009 | 73 | 0.090 |
Why?
|
Tunicamycin | 1 | 2009 | 112 | 0.090 |
Why?
|
Image Enhancement | 3 | 2015 | 2921 | 0.080 |
Why?
|
Echinococcus granulosus | 1 | 2008 | 10 | 0.080 |
Why?
|
Ephrins | 2 | 2005 | 27 | 0.080 |
Why?
|
Lentivirus | 1 | 2012 | 501 | 0.080 |
Why?
|
Glucose Transporter Type 1 | 1 | 2009 | 192 | 0.080 |
Why?
|
Arthrogryposis | 1 | 2009 | 72 | 0.080 |
Why?
|
Echinococcosis, Hepatic | 1 | 2008 | 24 | 0.080 |
Why?
|
Chimerin 1 | 1 | 2008 | 14 | 0.080 |
Why?
|
Models, Anatomic | 1 | 2013 | 691 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2022 | 63114 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 1992 | 497 | 0.080 |
Why?
|
Pyridines | 2 | 2017 | 2825 | 0.080 |
Why?
|
Haploinsufficiency | 1 | 2010 | 328 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2012 | 525 | 0.080 |
Why?
|
Threonine | 1 | 2009 | 279 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 480 | 0.080 |
Why?
|
Oncogene Protein v-akt | 1 | 2008 | 135 | 0.080 |
Why?
|
Pain | 1 | 2023 | 4986 | 0.080 |
Why?
|
Cell Count | 1 | 2012 | 1856 | 0.080 |
Why?
|
Sesquiterpenes | 1 | 2009 | 177 | 0.080 |
Why?
|
Cytoplasmic Granules | 1 | 2011 | 610 | 0.080 |
Why?
|
Brain Mapping | 4 | 2021 | 6669 | 0.080 |
Why?
|
In Situ Hybridization | 4 | 2001 | 1950 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 489 | 0.080 |
Why?
|
Zebrafish | 3 | 2020 | 2994 | 0.080 |
Why?
|
Hypopigmentation | 1 | 2008 | 41 | 0.080 |
Why?
|
Video Recording | 3 | 2018 | 949 | 0.080 |
Why?
|
Prefrontal Cortex | 1 | 2018 | 2147 | 0.080 |
Why?
|
Duane Retraction Syndrome | 1 | 2008 | 60 | 0.080 |
Why?
|
Retrospective Studies | 13 | 2024 | 77449 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10943 | 0.080 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1005 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3597 | 0.080 |
Why?
|
Motor Activity | 1 | 2017 | 2714 | 0.080 |
Why?
|
Syndrome | 3 | 2009 | 3251 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10397 | 0.070 |
Why?
|
Retinal Ganglion Cells | 2 | 2010 | 770 | 0.070 |
Why?
|
Chick Embryo | 2 | 2008 | 982 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3046 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5615 | 0.070 |
Why?
|
Astrocytes | 2 | 2017 | 1270 | 0.070 |
Why?
|
Sleep | 2 | 2020 | 4623 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4838 | 0.070 |
Why?
|
Pattern Recognition, Visual | 1 | 2012 | 824 | 0.070 |
Why?
|
Heme Oxygenase-1 | 1 | 2009 | 381 | 0.070 |
Why?
|
Pregnancy, High-Risk | 1 | 2007 | 120 | 0.070 |
Why?
|
Models, Statistical | 3 | 2018 | 5102 | 0.070 |
Why?
|
Lactones | 1 | 2009 | 329 | 0.070 |
Why?
|
Face | 1 | 2012 | 994 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14722 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 205 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1880 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4034 | 0.070 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 1144 | 0.070 |
Why?
|
Transduction, Genetic | 1 | 2009 | 913 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2005 | 2839 | 0.070 |
Why?
|
Abnormalities, Multiple | 2 | 2011 | 1416 | 0.070 |
Why?
|
Receptor Aggregation | 1 | 2005 | 80 | 0.070 |
Why?
|
Maternal Exposure | 1 | 2012 | 961 | 0.070 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2010 | 604 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4186 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15540 | 0.060 |
Why?
|
Visual Pathways | 1 | 2010 | 565 | 0.060 |
Why?
|
Serine | 1 | 2009 | 826 | 0.060 |
Why?
|
Transcription Factors | 5 | 2021 | 12208 | 0.060 |
Why?
|
Cytoplasm | 1 | 2010 | 1539 | 0.060 |
Why?
|
Caenorhabditis elegans | 2 | 2013 | 1419 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8642 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2020 | 7880 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8089 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 1351 | 0.060 |
Why?
|
Organ Size | 3 | 2018 | 2252 | 0.060 |
Why?
|
Caregivers | 1 | 2016 | 2094 | 0.060 |
Why?
|
Demyelinating Diseases | 1 | 2007 | 354 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2015 | 7722 | 0.060 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 430 | 0.060 |
Why?
|
Bicuculline | 2 | 2016 | 99 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2006 | 247 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2751 | 0.060 |
Why?
|
Middle Aged | 6 | 2023 | 213383 | 0.060 |
Why?
|
Consensus | 2 | 2023 | 2959 | 0.060 |
Why?
|
Amino Acid Sequence | 5 | 2008 | 13815 | 0.060 |
Why?
|
Parents | 3 | 2022 | 3407 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3508 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2016 | 5974 | 0.060 |
Why?
|
Pregnancy | 4 | 2022 | 29144 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5510 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2011 | 1403 | 0.060 |
Why?
|
Genes, Dominant | 2 | 2021 | 880 | 0.060 |
Why?
|
Intermediate Filaments | 1 | 2023 | 175 | 0.050 |
Why?
|
Nerve Regeneration | 1 | 2008 | 788 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1995 | 1581 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3527 | 0.050 |
Why?
|
Poloxamer | 1 | 2022 | 57 | 0.050 |
Why?
|
Algorithms | 5 | 2018 | 13881 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2021 | 9648 | 0.050 |
Why?
|
Psychometrics | 2 | 2023 | 3002 | 0.050 |
Why?
|
Paraplegia | 1 | 2023 | 168 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3772 | 0.050 |
Why?
|
Prevalence | 4 | 2021 | 15226 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5686 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Infant, Newborn, Diseases | 1 | 2008 | 582 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3647 | 0.050 |
Why?
|
Retinoids | 1 | 2022 | 101 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Risk Factors | 5 | 2020 | 72290 | 0.050 |
Why?
|
Pilot Projects | 3 | 2022 | 8324 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2007 | 1850 | 0.050 |
Why?
|
Monoacylglycerol Lipases | 1 | 2022 | 48 | 0.050 |
Why?
|
Gangliosides | 1 | 2022 | 137 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 7023 | 0.050 |
Why?
|
Muscle Spasticity | 1 | 2022 | 154 | 0.050 |
Why?
|
Calpain | 1 | 2022 | 150 | 0.050 |
Why?
|
Mutant Proteins | 1 | 2023 | 500 | 0.050 |
Why?
|
Axonal Transport | 1 | 2022 | 177 | 0.050 |
Why?
|
Sphingolipids | 1 | 2022 | 159 | 0.050 |
Why?
|
Pentobarbital | 1 | 2001 | 155 | 0.050 |
Why?
|
Stereotyped Behavior | 1 | 2021 | 136 | 0.050 |
Why?
|
Cerebellar Nuclei | 1 | 2021 | 52 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2001 | 94 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2001 | 6489 | 0.050 |
Why?
|
Cell Survival | 4 | 2012 | 5882 | 0.050 |
Why?
|
Endocytosis | 1 | 2005 | 985 | 0.050 |
Why?
|
Adaptor Protein Complex beta Subunits | 1 | 2020 | 13 | 0.050 |
Why?
|
United States | 5 | 2022 | 69872 | 0.050 |
Why?
|
Brain Edema | 1 | 2005 | 617 | 0.050 |
Why?
|
Intelligence Tests | 1 | 2021 | 505 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 2021 | 165 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2948 | 0.050 |
Why?
|
Anesthesia | 1 | 2011 | 1561 | 0.050 |
Why?
|
Cytoskeleton | 1 | 2005 | 1185 | 0.040 |
Why?
|
Midazolam | 1 | 2001 | 270 | 0.040 |
Why?
|
Actins | 2 | 2005 | 2121 | 0.040 |
Why?
|
Centrioles | 1 | 2020 | 79 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15076 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4456 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6171 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2021 | 253 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 441 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5137 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 426 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3462 | 0.040 |
Why?
|
Fibroblasts | 3 | 2020 | 4161 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2001 | 417 | 0.040 |
Why?
|
Intelligence | 1 | 2023 | 920 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 1999 | 194 | 0.040 |
Why?
|
Hallucinations | 1 | 2000 | 360 | 0.040 |
Why?
|
Dependovirus | 1 | 2023 | 706 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3617 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 21746 | 0.040 |
Why?
|
Biological Assay | 1 | 2021 | 652 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 783 | 0.040 |
Why?
|
Hemodiafiltration | 1 | 2017 | 20 | 0.040 |
Why?
|
Telemetry | 1 | 2018 | 205 | 0.040 |
Why?
|
Drug Resistance | 1 | 2003 | 1609 | 0.040 |
Why?
|
Photic Stimulation | 2 | 2015 | 2025 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2018 | 547 | 0.040 |
Why?
|
Health Priorities | 1 | 2020 | 380 | 0.040 |
Why?
|
Facies | 1 | 2017 | 197 | 0.040 |
Why?
|
Learning | 2 | 2019 | 1713 | 0.040 |
Why?
|
Prognosis | 4 | 2018 | 29063 | 0.040 |
Why?
|
Los Angeles | 1 | 2017 | 238 | 0.040 |
Why?
|
Language | 2 | 2019 | 1471 | 0.040 |
Why?
|
Decontamination | 1 | 2017 | 69 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13695 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 631 | 0.040 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 2016 | 62 | 0.040 |
Why?
|
Protein Kinase C | 1 | 2021 | 1227 | 0.040 |
Why?
|
DNA Primers | 2 | 2008 | 2892 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 879 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2861 | 0.040 |
Why?
|
Plasmapheresis | 1 | 2017 | 211 | 0.040 |
Why?
|
Neuroglia | 1 | 2022 | 927 | 0.030 |
Why?
|
Long-Term Synaptic Depression | 1 | 2016 | 59 | 0.030 |
Why?
|
Immune System | 1 | 2022 | 805 | 0.030 |
Why?
|
Cycloheximide | 1 | 2016 | 347 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 3 | 1 | 1995 | 4 | 0.030 |
Why?
|
Zinc Fingers | 1 | 1998 | 585 | 0.030 |
Why?
|
Wavelet Analysis | 1 | 2015 | 57 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39050 | 0.030 |
Why?
|
Conditioning, Eyelid | 1 | 2015 | 10 | 0.030 |
Why?
|
Microscopy, Confocal | 2 | 2016 | 1970 | 0.030 |
Why?
|
Dendrites | 2 | 2009 | 485 | 0.030 |
Why?
|
Ligands | 2 | 2014 | 3282 | 0.030 |
Why?
|
Gestational Age | 2 | 1995 | 3493 | 0.030 |
Why?
|
Information Theory | 1 | 2015 | 51 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2016 | 214 | 0.030 |
Why?
|
Computer Simulation | 3 | 2015 | 6196 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10388 | 0.030 |
Why?
|
Affect | 1 | 2023 | 1476 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2022 | 1017 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12245 | 0.030 |
Why?
|
Propofol | 1 | 2001 | 629 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2016 | 302 | 0.030 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2014 | 13 | 0.030 |
Why?
|
Thalamic Nuclei | 1 | 1995 | 114 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3689 | 0.030 |
Why?
|
Growth Substances | 1 | 2017 | 784 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2001 | 1462 | 0.030 |
Why?
|
Motion | 1 | 2018 | 798 | 0.030 |
Why?
|
Testis | 1 | 1998 | 803 | 0.030 |
Why?
|
Ephrin-A5 | 1 | 2014 | 16 | 0.030 |
Why?
|
Glutathione | 1 | 2017 | 589 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2016 | 373 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1086 | 0.030 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2014 | 57 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1998 | 2050 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1584 | 0.030 |
Why?
|
Antisense Elements (Genetics) | 1 | 1993 | 37 | 0.030 |
Why?
|
Dark Adaptation | 1 | 2015 | 219 | 0.030 |
Why?
|
RNA Probes | 1 | 1993 | 113 | 0.030 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2014 | 90 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1090 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1484 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 547 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2008 | 18111 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2023 | 3420 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1660 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 783 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5078 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2008 | 20129 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2015 | 535 | 0.030 |
Why?
|
Insulin | 1 | 2008 | 6580 | 0.030 |
Why?
|
Statistical Distributions | 1 | 2013 | 64 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2005 | 4577 | 0.030 |
Why?
|
Histology | 1 | 2012 | 16 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1993 | 438 | 0.030 |
Why?
|
Acute Disease | 1 | 2003 | 7149 | 0.030 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1992 | 36 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4933 | 0.030 |
Why?
|
Synapsins | 1 | 2012 | 43 | 0.030 |
Why?
|
RNA Interference | 2 | 2012 | 2889 | 0.030 |
Why?
|
Base Sequence | 3 | 2008 | 12797 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12959 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 2 | 2005 | 464 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1184 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3558 | 0.030 |
Why?
|
Enkephalins | 1 | 1992 | 154 | 0.030 |
Why?
|
Survival | 1 | 2012 | 163 | 0.030 |
Why?
|
Wakefulness | 1 | 2018 | 1245 | 0.030 |
Why?
|
Pyramidal Cells | 1 | 2014 | 363 | 0.020 |
Why?
|
Iron | 1 | 2020 | 1774 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2749 | 0.020 |
Why?
|
Biopsy | 1 | 2003 | 6756 | 0.020 |
Why?
|
Autoradiography | 1 | 1992 | 745 | 0.020 |
Why?
|
Language Disorders | 1 | 2012 | 141 | 0.020 |
Why?
|
Sodium Compounds | 1 | 2011 | 30 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2014 | 551 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 1992 | 182 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2016 | 1767 | 0.020 |
Why?
|
Motor Skills | 1 | 2014 | 522 | 0.020 |
Why?
|
Arsenites | 1 | 2011 | 66 | 0.020 |
Why?
|
Horseradish Peroxidase | 1 | 1990 | 166 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9438 | 0.020 |
Why?
|
CA1 Region, Hippocampal | 1 | 2011 | 112 | 0.020 |
Why?
|
Vision, Ocular | 1 | 2014 | 464 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13284 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2186 | 0.020 |
Why?
|
Gene Library | 1 | 1993 | 1074 | 0.020 |
Why?
|
Sample Size | 1 | 2014 | 845 | 0.020 |
Why?
|
Benzamides | 1 | 2016 | 1379 | 0.020 |
Why?
|
PC12 Cells | 1 | 2011 | 330 | 0.020 |
Why?
|
Poly I-C | 1 | 2010 | 115 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2886 | 0.020 |
Why?
|
Organ Specificity | 1 | 1995 | 2008 | 0.020 |
Why?
|
Cytoprotection | 1 | 2011 | 210 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2011 | 190 | 0.020 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2009 | 31 | 0.020 |
Why?
|
Adenylate Kinase | 1 | 2010 | 100 | 0.020 |
Why?
|
HeLa Cells | 2 | 2006 | 3128 | 0.020 |
Why?
|
Dentate Gyrus | 1 | 2010 | 160 | 0.020 |
Why?
|
Artifacts | 1 | 2018 | 1904 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2010 | 270 | 0.020 |
Why?
|
Cats | 1 | 1990 | 998 | 0.020 |
Why?
|
Lithium Chloride | 1 | 2009 | 87 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 2015 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 1990 | 410 | 0.020 |
Why?
|
Nerve Crush | 1 | 2008 | 78 | 0.020 |
Why?
|
Chemotaxis | 1 | 2012 | 607 | 0.020 |
Why?
|
Axotomy | 1 | 2008 | 73 | 0.020 |
Why?
|
Abducens Nerve | 1 | 2008 | 28 | 0.020 |
Why?
|
Ribosomal Protein S6 | 1 | 2008 | 70 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 867 | 0.020 |
Why?
|
Granulocytes | 1 | 1990 | 548 | 0.020 |
Why?
|
Isoenzymes | 1 | 1993 | 1726 | 0.020 |
Why?
|
Angelman Syndrome | 1 | 2010 | 136 | 0.020 |
Why?
|
Light | 1 | 2015 | 1374 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12026 | 0.020 |
Why?
|
Oculomotor Nerve | 1 | 2008 | 74 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4420 | 0.020 |
Why?
|
Blood Vessels | 1 | 2014 | 1125 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 643 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2645 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2009 | 528 | 0.020 |
Why?
|
Phenylbutyrates | 1 | 2008 | 69 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2017 | 1786 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9849 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1785 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2015 | 2480 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2008 | 149 | 0.020 |
Why?
|
DNA | 1 | 2021 | 7301 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23338 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6622 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2011 | 731 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1547 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1775 | 0.020 |
Why?
|
Nicotine | 1 | 1992 | 681 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2008 | 2916 | 0.020 |
Why?
|
Electroporation | 1 | 2008 | 251 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2007 | 428 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9687 | 0.020 |
Why?
|
Reaction Time | 1 | 2012 | 2097 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 563 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 1972 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13408 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 1706 | 0.020 |
Why?
|
Optic Nerve | 1 | 2008 | 554 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4468 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3158 | 0.020 |
Why?
|
Oculomotor Muscles | 1 | 2008 | 371 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2699 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2006 | 964 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2006 | 802 | 0.010 |
Why?
|
Neoplasms | 2 | 2010 | 21683 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2006 | 853 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5720 | 0.010 |
Why?
|
Genetic Techniques | 1 | 2006 | 435 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1097 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3507 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1294 | 0.010 |
Why?
|
Autoantibodies | 1 | 2011 | 2035 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1157 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2009 | 861 | 0.010 |
Why?
|
Aged | 3 | 2022 | 163280 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9386 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3701 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2649 | 0.010 |
Why?
|
Cell Membrane | 1 | 2008 | 3748 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4669 | 0.010 |
Why?
|
Cell Communication | 1 | 2005 | 1621 | 0.010 |
Why?
|
Immunoblotting | 1 | 2001 | 1682 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2001 | 981 | 0.010 |
Why?
|
Spermatogenesis | 1 | 1998 | 262 | 0.010 |
Why?
|
Spinal Cord | 1 | 2005 | 1809 | 0.010 |
Why?
|
Eye | 1 | 2001 | 729 | 0.010 |
Why?
|
Skin | 1 | 2009 | 4364 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4320 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 4803 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2008 | 3864 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3846 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 2803 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1990 | 9274 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10481 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12788 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2008 | 15295 | 0.000 |
Why?
|